or Try an Advanced Search...

    Technical Analysis for ANAB - AnaptysBio, Inc.

    Grade Last Price % Change Price Change
    D 19.83 -7.64% -1.64
    ANAB closed down 7.64 percent on Thursday, April 18, 2024, on approximately normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 9
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ANAB trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Fell Below 200 DMA Bearish 0.00%
    MACD Bearish Signal Line Cross Bearish 0.00%
    180 Bearish Setup Bearish Swing Setup 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Multiple of Ten Bearish Other 0.00%
    Outside Day Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Hammer Candlestick Bullish -7.64%
    NR7 Range Contraction -7.64%
    Older End-of-Day Signals for ANAB ...

       Recent Intraday Alerts

    Alert Time
    Fell Below 200 DMA about 11 hours ago
    Down 1 ATR about 11 hours ago
    Down 5% about 13 hours ago
    10 DMA Resistance about 15 hours ago
    Outside Day about 15 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ANAB Chart by TradingView
    Basic chart:

    Profile

    AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Antibodies Inflammation

    Is ANAB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 9 Why You Shouldn't Bet Against AnaptysBio (ANAB) Stock.
    Mar 18 Industry Analysts Just Made A Stunning Upgrade To Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts
    Mar 14 What Makes AnaptysBio, Inc. (ANAB) a New Buy Stock
    Mar 14 Wall Street Analysts Believe AnaptysBio, Inc. (ANAB) Could Rally 69.62%: Here's is How to Trade
    Mar 14 Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
    Mar 12 Wedbush raises AnaptysBio to outperform, cites upcoming data
    Feb 22 13 Best Short Squeeze Stocks To Buy Now
    Feb 21 Stifel starts AnaptysBio at buy, cites upcoming catalysts
    Feb 19 Strength Seen in AnaptysBio, Inc. (ANAB): Can Its 5.9% Jump Turn into More Strength?
    Feb 16 AnaptysBio gains as Piper Sandler starts at Overweight on catalyst path
    See more ANAB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 27.5
    52 Week Low 13.36
    Average Volume 333,817
    200-Day Moving Average 20.07
    50-Day Moving Average 23.31
    20-Day Moving Average 21.69
    10-Day Moving Average 21.68
    Average True Range 1.50
    RSI (14) 39.39
    ADX 14.2
    +DI 22.41
    -DI 26.11
    Chandelier Exit (Long, 3 ATRs) 21.11
    Chandelier Exit (Short, 3 ATRs) 24.29
    Upper Bollinger Bands 23.99
    Lower Bollinger Band 19.38
    Percent B (%b) 0.1
    BandWidth 21.22
    MACD Line -0.58
    MACD Signal Line -0.54
    MACD Histogram -0.0437
    Fundamentals Value
    Market Cap 526.99 Million
    Num Shares 26.6 Million
    EPS -5.42
    Price-to-Earnings (P/E) Ratio -3.66
    Price-to-Sales 40.64
    Price-to-Book 5.09
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 22.82
    Resistance 3 (R3) 23.14 22.46 22.32
    Resistance 2 (R2) 22.46 21.70 22.30 22.16
    Resistance 1 (R1) 21.15 21.23 20.81 20.83 21.99
    Pivot Point 20.47 20.47 20.30 20.31 20.47
    Support 1 (S1) 19.15 19.70 18.81 18.83 17.67
    Support 2 (S2) 18.47 19.23 18.31 17.50
    Support 3 (S3) 17.16 18.47 17.34
    Support 4 (S4) 16.84